China
# |
Name |
Receivables |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.35 B
|
Dec. 31, 2023 | USD 2.91 | 1.87% |
|
China |
|
2 |
USD 1.20 B
|
Dec. 31, 2023 | USD 1.46 | 3.48% |
|
China |
|
3 |
USD 1.03 B
|
Dec. 31, 2023 | USD 0.96 | 5.88% |
|
China |
|
4 |
USD 832.88 M
|
Dec. 31, 2023 | USD 2.05 | 4.96% |
|
China |
|
5 |
USD 760.50 M
|
Dec. 31, 2023 | USD 3.54 | 2.01% |
|
China |
|
6 |
USD 470.75 M
|
Dec. 31, 2023 | USD 0.89 | 4.83% |
|
China |
|
7 |
USD 461.30 M
|
Dec. 31, 2023 | USD 0.61 | 2.08% |
|
China |
|
8 |
USD 315.11 M
|
Dec. 31, 2023 | USD 1.73 | 3.02% |
|
China |
|
9 |
USD 245.11 M
|
Dec. 31, 2023 | USD 0.59 | 5.88% |
|
China |
|
10 |
USD 226.46 M
|
Dec. 31, 2023 | USD 0.95 | 5.61% |
|
China |
|
11 |
USD 220.65 M
|
Dec. 31, 2023 | USD 0.49 | 1.30% |
|
China |
|
12 |
USD 213.46 M
|
Dec. 31, 2023 | USD 0.77 | -0.19% |
|
China |
|
13 |
USD 145.38 M
|
Dec. 31, 2023 | USD 0.35 | 4.04% |
|
China |
|
14 |
USD 109.17 M
|
Dec. 31, 2023 | USD 3.10 | 4.27% |
|
China |
|
15 |
USD 99.55 M
|
Dec. 31, 2023 | USD 3.65 | 3.06% |
|
China |
|
16 |
USD 93.20 M
|
Dec. 31, 2023 | USD 0.70 | 6.67% |
|
China |
|
17 |
USD 85.89 M
|
Dec. 31, 2023 | USD 0.40 | 4.60% |
|
China |
|
18 |
USD 81.70 M
|
Dec. 31, 2023 | USD 0.15 | -0.02% |
|
China |
|
19 |
USD 77.28 M
|
Dec. 31, 2023 | USD 3.18 | 2.29% |
|
China |
|
20 |
USD 59.22 M
|
Dec. 31, 2023 | USD 1.50 | 1.37% |
|
China |
|
21 |
USD 50.33 M
|
Dec. 31, 2023 | USD 1.73 | 4.28% |
|
China |
|
22 |
USD 42.18 M
|
Dec. 31, 2023 | USD 0.16 | -0.02% |
|
China |
|
23 |
USD 27.16 M
|
Dec. 31, 2023 | USD 1.43 | 5.22% |
|
China |
|
24 |
USD 25.48 M
|
Dec. 31, 2023 | USD 0.49 | 4.39% |
|
China |
|
25 |
USD 23.12 M
|
Dec. 31, 2023 | USD 0.10 | -1.24% |
|
China |
|
26 |
USD 19.37 M
|
Dec. 31, 2023 | USD 5.73 | 2.34% |
|
China |
|
27 |
USD 14.49 M
|
Dec. 31, 2023 | USD 1.19 | 4.42% |
|
China |
|
28 |
USD 10.35 M
|
Dec. 31, 2023 | USD 4.77 | 5.76% |
|
China |
|
29 |
USD 8.67 M
|
Dec. 31, 2023 | USD 2.79 | 4.08% |
|
China |
|
30 |
USD 4.46 M
|
Dec. 31, 2023 | USD 0.27 | 0.02% |
|
China |
|
31 |
USD 3.83 M
|
Dec. 31, 2023 | USD 1.47 | 3.46% |
|
China |
|
32 |
USD 3.02 M
|
Dec. 31, 2023 | USD 1.80 | 2.86% |
|
China |
|
33 |
USD 0.00
|
Dec. 31, 2023 | USD 0.61 | 1.47% |
|
China |
|
34 |
USD 0.00
|
March 31, 2024 | USD 0.30 | 0.41% |
|
China |
The Hospitals & Clinics company in China with the highest Receivables is Humanwell Healthcare (Group) Co.,Ltd. (Shanghai Stock Exchange: 600079.SS) at USD 1.35 B.
The Hospitals & Clinics company in China with the lowest Receivables is Arrail Group Limited (HKSE: 6639.HK) at USD 0.00.
The top 10 Hospitals & Clinics companies in China by Receivables are Humanwell Healthcare (Group) Co.,Ltd., Dian Diagnostics Group Co.,Ltd., DHC Software Co.,Ltd., Shanghai Runda Medical Technology Co., Ltd., Guangzhou Kingmed Diagnostics Group Co., Ltd., Winning Health Technology Group Co., Ltd., Meinian Onehealth Healthcare Holdings Co., Ltd., Aier Eye Hospital Group Co., Ltd., B-SOFT Co.,Ltd. and Thalys Medical Technology Group Inc..
The bottom 10 Hospitals & Clinics companies in China by Receivables are Arrail Group Limited, Genertec Universal Medical Group Company Limited, Zhongchao Inc., Ningbo David Medical Device Co., Ltd., Honliv Healthcare Management Group Company Limited, Shanghai Sanyou Medical Co., Ltd., Concord Medical Services Holdings Limited, Innovation Medical Management Co., Ltd., Topchoice Medical Corporation and Neusoft Xikang Holdings Inc.